Edgewise Therapeutics Announces Publication of Skeletal Muscle Research for Duchenne

April 7, 2023

On March 30, 2023, Edgewise Therapeutics announced the publication of the article, “Modulating fast
skeletal muscle contraction protects skeletal muscle in the animal models of Duchenne muscular dystrophy,” in the Journal of Clinical Investigation.

To read Edgewise press release, please click here.

To read the research article, please click here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open